Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Galaxy $402.5 million exchangeable senior notes offering
We advised Galaxy on its offering
Alignment Healthcare $330 million convertible senior notes offering
The convertible notes are due 2029
ACELYRIN $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Spirit Airlines prearranged chapter 11 filing
We are advising Spirit Airlines in connection with entry into an RSA and negotiation of a prearranged chapter 11 plan
Morgan Stanley $3 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Cardinal Health $2.9 billion notes offering
The investment-grade notes are due 2026, 2029, 2034 and 2054
Equinix €1.15 billion green bond offering
We advised Equinix on the euro notes offering
Omnicell $172.5 million convertible senior notes offering
The convertible senior notes are due 2029
General Mills $1.5 billion notes offering
The investment-grade notes are due 2030 and 2035
MicroStrategy $3 billion convertible notes offering
The convertible notes are due 2029